Blog Where innovation, insight & ideas combine. Contact Us Ask The Experts Home Blog Translational Pharmaceutics, Dr. Helen Baker, Dr. Vanessa Zann, Drug Development Consulting, Drug Product, Philadelphia, Miami Accelerating Drug Development with Translational Pharmaceutics® Read Now Categories View all categories14C Radiolabeling505(b)(2)AlnwickBioanalysisBiopharmaceuticsBlogCandidate DevelopmentCandidate SelectionCareersClinical PharmacologyClinical Trial ManufacturingClinical Trial SuppliesColleague StoriesCommercial ManufacturingCorporate UpdatesCRDMOData SciencesDenise SuttonDennis HendersonDr. Adam Robinson-MillerDr. Andrew LewisDr. Aruna RailkarDr. Asma PatelDr. Gareth JenkinsDr. Helen BakerDr. Peter ScholesDr. Richard Castledine Dr. Stuart MairDr. Stuart McDougallDr. Vanessa ZannDrug Development ConsultingDrug ProductDrug Product OptimizationDrug Substance to Drug ProductEarly DevelopmentFirst-in-HumanFormulation DevelopmentFreeThink ASAPprimeGamma ScintigraphyGLP-1 TherapeuticsHealthy Volunteer TrialsHelen BakerHigh Potency APIsHuman ADMEIain ShawIan NisbetICP-MSIndustry CollaborationInhalationJohn EntwistleJohn McDermottKevser SevimLate DevelopmentMartin Wing-KingMiamiMicrobiologyModeling and SimulationModified ReleaseNazim KanjiNichole CaparelliNottinghamOmer AlpOncologyOrphan DrugsOrphan RarePaige BellisPediatricsPeptidesPharmacy CompoundingPhase 1 TrialsPhiladelphiaPR&DProject ManagementQuality AssuranceRare DiseasesReadingRegulatoryScientific AchievementsScientific InnovationScintigraphySite SpotlightSolid-State CharacterizationSolubility EnhancementThierry Van NieuwenhoveDrug SubstanceIntegrated ProgramsSustainabilityTranslational Pharmaceutics Publish Date View all time20252024202320222021202020192018 Fulltext search 21 - 25 of 122 results Human ADME, Regulatory, Dr. Adam Robinson-MillerAssessing the Impact of the Approved FDA Guidance on Human Mass Balance Studies: How ADME programs will proceed in 2024 and beyondHuman ADME, Regulatory, Dr. Adam Robinson-MillerAssessing the Impact of the Approved FDA Guidance on Human Mass Balance Studies: How ADME programs will proceed in 2024 and beyondLearn more Bioanalysis, Drug Substance, Paige BellisMicrowave Digestion to Support ICP-MS Sample Analysis Bioanalysis, Drug Substance, Paige BellisMicrowave Digestion to Support ICP-MS Sample Analysis Learn more Drug Product, Integrated Programs, Dr. Asma Patel, Rare Diseases, Orphan DrugsAccelerated pathways and CMC challenges in rare disease drug developmentDrug Product, Integrated Programs, Dr. Asma Patel, Rare Diseases, Orphan DrugsAccelerated pathways and CMC challenges in rare disease drug developmentLearn more Philadelphia, Quality Assurance, Nichole CaparelliSpotlight on Quality: Interview with Nichole CaparelliPhiladelphia, Quality Assurance, Nichole CaparelliSpotlight on Quality: Interview with Nichole CaparelliLearn more Thierry Van Nieuwenhove, Translational Pharmaceutics, Integrated Programs, Drug Product, Clinical PharmacologyInterview with Thierry Van Nieuwenhove: On Quotient Sciences' Growth and Role in Accelerating Drug DevelopmentThierry Van Nieuwenhove, Translational Pharmaceutics, Integrated Programs, Drug Product, Clinical PharmacologyInterview with Thierry Van Nieuwenhove: On Quotient Sciences' Growth and Role in Accelerating Drug DevelopmentLearn more Pagination First page « First Previous page ‹ Previous … Page 3 Page 4 Page 5 Page 6 Page 7 … Next page Next › Last page Last » Learn more about Quotient Sciences At a Glance We are a drug development and manufacturing accelerator for the global pharmaceutical industry. Learn More Our Locations Access directions and information about our facilities in the US & UK. Browse Locations Careers See what life is like at Quotient Sciences and how you can join our global team. Browse Jobs Get in touch Humanity can't afford to wait, so neither can we. Let's talk
